Abstract

Background: The immunoglobulin G synthesis rate (IgG SR) and immunoglobulin G (IgG) index are indicators of abnormal intrathecal humoural immune responses, and the albumin quotient (QALB) is an indicator used to evaluate the completeness of the blood-cerebrospinal fluid barrier (BCB). No systematic reports regarding differences in Guillain-Barré syndrome (GBS) and chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) are available. We assessed differences in the IgG SR, IgG index and QALB between GBS and CIDP patients in a Chinese cohort.Methods: A total of 234 patients were retrospectively enrolled in this study, and 167 clinically confirmed GBS and CIDP patients were selected. Meanwhile, 67 non-GBS and non-CIDP patients requiring cerebrospinal fluid (CSF) examination were enrolled as the control group. The IgG SR, IgG index and QALB were calculated using formulas. The relevant clinical data were subjected to statistical analysis.Results: Among the GBS and CIDP study groups and the control group, the QALB had the highest positive rate (80.00%) in the CIDP group (P < 0.01). The QALB stratification analysis showed that the ranges of 10 < QALB ≤ 30 were dominant in the GBS and CIDP groups, and the positive rate of CIDP was higher than that of GBS. Furthermore, a QALB ≤ 7 was dominant in the control group, and a QALB > 30 was dominant in the CIDP group. In receiver operating characteristic (ROC) curve analysis with the CIDP group as the trial group and the GBS group as the control group, the differences in the QALB were statistically significant (P < 0.01). To achieve a high specificity of 98~99%, the diagnostic cut-off value for the QALB was above 57.37 (sensitivity: 9.33%) or below 0.60 (sensitivity: 4.35%). Multivariate logistic regression analysis showed that the CIDP patients had a QALB higher than 57.37, and compared with that in the GBS patients, the difference in the QALB was statistically significant (P < 0.01).Conclusion: QALB elevation was associated with CIDP, while QALB values above 57.37 or below 0.60 had high specificity in differentiating between GBS and CIDP. In CIDP, the BCB is generally moderately to severely damaged; in GBS, the BCB is generally moderately damaged.

Highlights

  • Guillain-Barré syndrome (GBS) is an immune-mediated demyelinating disease of the peripheral nervous system (PNS) and spinal root and is characterized by the rapid progression of symmetric weakness, disappearance of tendon reflexes, electrophysiological characteristics of demyelination, dysfunction of the blood-cerebrospinal fluid barrier (BCB) and normal cell counts

  • The inclusion criteria included [1] a diagnosis of GBS or Chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) at Beijing Tiantan Hospital, Capital Medical University according to the Guillain–Barré and Miller-Fisher syndromes— new diagnostic classification [5] and the European Federation of Neurological Societies/Peripheral Nerve Society Guidelines for the management of chronic inflammatory demyelinating polyradiculoneuropathy [6]; [2] an age ranging from 18 to 83 years; [3] complete clinical outcome data, including sex, age, cerebrospinal fluid (CSF) examinations, immunoglobulin G (IgG) SR, additional blood biochemistry, thyroid antibody, autoimmune antibody spectrum and other examinations; and [4] Hughes Functional Grading Scale (HFGS) score ≤4 at the peak of the disease in the GBS and CIDP groups

  • Control Group Non-GBS and non-CIDP patients hospitalized between October 2014 and April 2020 who required CSF examination were enrolled as the control group

Read more

Summary

Introduction

Guillain-Barré syndrome (GBS) is an immune-mediated demyelinating disease of the peripheral nervous system (PNS) and spinal root and is characterized by the rapid progression of symmetric weakness, disappearance of tendon reflexes, electrophysiological characteristics of demyelination, dysfunction of the blood-cerebrospinal fluid barrier (BCB) and normal cell counts. When the BCB is damaged by CNS diseases, such proteins can cross the blood-brain barrier (BBB) and enter the cerebrospinal fluid (CSF). The IgG synthesis rate (IgG SR) and IgG index are important indicators of abnormal intrathecal humoural immune responses. The immunoglobulin G synthesis rate (IgG SR) and immunoglobulin G (IgG) index are indicators of abnormal intrathecal humoural immune responses, and the albumin quotient (QALB) is an indicator used to evaluate the completeness of the blood-cerebrospinal fluid barrier (BCB). No systematic reports regarding differences in Guillain-Barré syndrome (GBS) and chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) are available. We assessed differences in the IgG SR, IgG index and QALB between GBS and CIDP patients in a Chinese cohort

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call